CN104815092A - Traditional Chinese medicine composition for treating chronic pelvic inflammation - Google Patents
Traditional Chinese medicine composition for treating chronic pelvic inflammation Download PDFInfo
- Publication number
- CN104815092A CN104815092A CN201510232599.6A CN201510232599A CN104815092A CN 104815092 A CN104815092 A CN 104815092A CN 201510232599 A CN201510232599 A CN 201510232599A CN 104815092 A CN104815092 A CN 104815092A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- chronic pelvic
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating chronic pelvic inflammation and belongs to the field of traditional Chinese medicine. The traditional Chinese medicine is characterized by being prepared from following raw materials, by weight, 9 parts of the bark of ash, 9 parts of pulsatilla chinensis, 18 parts of sargentodoxa cuneata, 6 parts of rhizoma alismatis, 10 parts of fructus akebia, 10 parts of red peony roots, 15 parts of corydalis yanhusuo, 15 parts of spina gleditsiae, 15 parts of seaweeds and 10 parts of honey-fried liquorice roots. The traditional Chinese medicine composition has the effects of clearing heat, removing toxin and draining dampness, regulating qi, activating blood and dissipating binds, and has significant effect of treating the chronic pelvic inflammation, is stable in curative effect and is free of toxic and side effects.
Description
Technical field:
The present invention relates to a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease, belong to the field of Chinese medicines.
Background technology:
The chronic inflammatory disease that chronic pelvic inflammatory disease refers to female pelvic cavity genitals and surrounding connective tissue thereof, pelvic peritoneum occurs, comprises chronic endometritis, salpingitis, tubo-ovarian abscess, pelvioperitonitis and inflammation of pelvic connective tissue etc.Inflammation can be confined to a position, also can involve several position simultaneously.The common lower abdominal pain of its clinical symptoms is uncomfortable, and the acid of waist sacrum is swollen, can with low thermal fluctuation, fatiguability, and leukorrhagia increases, menoxenia, infertile etc., even occurs neurasthenia symptom, as insomnia, tired etc.
Primary disease has the advantages that the course of disease is long, cure rate is low, relapse rate is high, though do not jeopardize patient vitals, but long-term chronic pelvic inflammation has had a strong impact on work and the quality of life of patient, become the social problem affecting vast Reproduction Health of Women, and sickness rate there is the trend significantly risen in recent years.
Doctor trained in Western medicine think chronic pelvic inflammatory disease system multiple pathogens mixed infection caused by, treatment adopts antibiotic more, but prolonged and repeated use antibiotic easily produces drug resistance, thus causes primary disease not easily to effect a radical cure.
Chinese medicine is thought, primary disease many by puerperal or menstrual period damp and hot heresy to take advantage of a weak point uterus, damp and hot fighting mutually with QI and blood forms.Clinically with clearing heat, detoxicating, dispelling dampness, vital energy regualting and blood circulation-promoting eliminating stagnation for principle for the treatment of, achieve good therapeutic effect.
Summary of the invention:
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease, it is characterized in that being made up of the raw material of Chinese medicine of following parts by weight:
Cortex Fraxini 9, the Radix Pulsatillae 9, Caulis Sargentodoxae 18, Rhizoma Alismatis 6, Fructus Akebiae 10, Radix Paeoniae Rubra 10, Rhizoma Corydalis 15, Spina Gleditsiae 15, Sargassum 15, Radix Glycyrrhizae Preparata 10.
Single dose (unit: gram): Cortex Fraxini 9, the Radix Pulsatillae 9, Caulis Sargentodoxae 18, Rhizoma Alismatis 6, Fructus Akebiae 10, Radix Paeoniae Rubra 10, Rhizoma Corydalis 15, Spina Gleditsiae 15, Sargassum 15, Radix Glycyrrhizae Preparata 10.
Preparation and instructions of taking: be decocted in water for oral dose, every day potion, sooner or later one after each meal at twice, all start medication in clean period after 3 days, taking medicine 30 doses is 1 course for the treatment of.Period in a medicine such as menstruation is risen again, suspends medicine, continues to take medicine after 3 days until clean period.
Side's Chinese medicine mechanism of the present invention is as follows:
Cortex Fraxini: heat-clearing and toxic substances removing, liver heat removing and eyesight improving.
The Radix Pulsatillae: heat-clearing and toxic substances removing, removing heat from blood.
Caulis Sargentodoxae: heat-clearing and toxic substances removing, promoting blood circulation and stopping pain.
Rhizoma Alismatis: promoting diuresis to eliminate damp pathogen, expels the heat-evil.
Fructus Akebiae: depressed liver-energy dispersing and QI regulating eliminating stagnation.
Radix Paeoniae Rubra: clearing away heat and cooling blood, eliminating stasis to stop pain.
Rhizoma Corydalis: invigorate blood circulation, circulation of qi promoting, pain relieving.
Spina Gleditsiae: expelling pus and toxin by strengthening QI, eliminating carbuncle of invigorating blood circulation.
Sargassum: eliminating phlegm and softening indurated mass, diuretic.
Radix Glycyrrhizae Preparata: invigorating the spleen and replenishing QI, nourishing the lung to arrest cough, relieving spasm to stop pain, relaxes the property of medicine.
After said medicine combines by the present invention, there is effect of clearing heat, detoxicating, dispelling dampness, vital energy regualting and blood circulation-promoting eliminating stagnation, in treatment chronic pelvic inflammatory disease, achieve significant effect, stable curative effect, have no side effect.
Below in conjunction with clinical trial and model case, the present invention will be further described.
One, clinical trial
1, clinical data: undergoing chronic pelvic inflammation 100 example choosing 25 years old ~ 40 years old, the course of disease differs in length.
2, Therapeutic Method: be decocted in water for oral dose, every day potion, sooner or later one after each meal at twice, all start medication in clean period after 3 days, taking medicine 30 doses is 1 course for the treatment of, takes medicine 60 doses altogether.Period in a medicine such as menstruation is risen again, suspends medicine, continues to take medicine after 3 days until clean period.
3, efficacy assessment standard:
Excellent: hypogastralgia and waist sacrum acid swollen transference cure or obviously alleviate, gynecologial examination and physico-chemical examination obviously improve;
Good: hypogastralgia and the swollen symptom of waist sacrum acid alleviate to some extent, and gynecologial examination and physico-chemical examination make moderate progress;
Difference: hypogastralgia and the swollen symptom of waist sacrum acid unchanged or increase the weight of to some extent, gynecologial examination and physico-chemical examination are without improvement or increase the weight of to some extent.
4, therapeutic outcome: after the treatment of 60 doses of medicines, excellent 35 examples, good 60 examples, differ from 5 examples, total effective rate 95%.
Two, model case:
Example one: Hao, female is 32 years old, married.Few abdomen both sides pain 2 years, repeatly through treatment, heavy time light during stomachache.Nearly colic symptoms over the past half year increases the weight of, and menstrual blood volume reduces, and leucorrhea with yellow discharge gas is dirty, row Abdominal B type ultrasonography shows pelvic hydrops, bilateral salpingo increases thick, is diagnosed as chronic pelvic inflammatory disease, and suffering from abdominal pain after oral Chinese medicine composition 30 doses subtracts greatly, after oral this medicine 60 doses, all diseases disappear substantially, follow up a case by regular visits to and do not recur for 1 year.
Example two: Qiu, female is 37 years old, married.Repeatedly more than the few abdominal part distending pain in right side uncomfortable half a year, row Abdominal MRI shows ride side attachment inflammatory mass, clinical diagnosis is chronic pelvic inflammatory disease, suffer from abdominal pain after oral Chinese medicine composition 30 doses and alleviate, after oral this medicine 60 doses, check Abdominal MRI shows that ride side attachment inflammatory mass disappears, and follows up a case by regular visits to and does not recur half a year.
Detailed description of the invention:
Embodiment
Press column weight amount grams and take raw material of Chinese medicine:
Cortex Fraxini 9, the Radix Pulsatillae 9, Caulis Sargentodoxae 18, Rhizoma Alismatis 6, Fructus Akebiae 10, Radix Paeoniae Rubra 10, Rhizoma Corydalis 15, Spina Gleditsiae 15, Sargassum 15, Radix Glycyrrhizae Preparata 10.
Preparation and instructions of taking: be decocted in water for oral dose, every day potion, sooner or later one after each meal at twice, all start medication in clean period after 3 days, taking medicine 30 doses is 1 course for the treatment of.Period in a medicine such as menstruation is risen again, suspends medicine, continues to take medicine after 3 days until clean period.
Claims (1)
1. treat a Chinese medicine composition for chronic pelvic inflammatory disease, it is characterized in that being made up of the raw material of Chinese medicine of following parts by weight: Cortex Fraxini 9, the Radix Pulsatillae 9, Caulis Sargentodoxae 18, Rhizoma Alismatis 6, Fructus Akebiae 10, Radix Paeoniae Rubra 10, court of a feudal ruler Rhizoma Corydalis 15, Spina Gleditsiae 15, Sargassum 15, Radix Glycyrrhizae Preparata 10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510232599.6A CN104815092A (en) | 2015-05-05 | 2015-05-05 | Traditional Chinese medicine composition for treating chronic pelvic inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510232599.6A CN104815092A (en) | 2015-05-05 | 2015-05-05 | Traditional Chinese medicine composition for treating chronic pelvic inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104815092A true CN104815092A (en) | 2015-08-05 |
Family
ID=53725735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510232599.6A Pending CN104815092A (en) | 2015-05-05 | 2015-05-05 | Traditional Chinese medicine composition for treating chronic pelvic inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104815092A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055702A (en) * | 2015-09-07 | 2015-11-18 | 南京正宽医药科技有限公司 | Pharmaceutical preparation for treating chronic pelvic inflammatory disease |
| CN105105251A (en) * | 2015-08-14 | 2015-12-02 | 沈凯 | Shaddock juice health beverage |
-
2015
- 2015-05-05 CN CN201510232599.6A patent/CN104815092A/en active Pending
Non-Patent Citations (2)
| Title |
|---|
| 王付: "《经方合方辨治疑难杂病》", 31 January 2014, 河南科学技术出版社 * |
| 邱翠华: "中西医结合治疗盆腔炎性包块40例观察", 《实用中医药杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105105251A (en) * | 2015-08-14 | 2015-12-02 | 沈凯 | Shaddock juice health beverage |
| CN105055702A (en) * | 2015-09-07 | 2015-11-18 | 南京正宽医药科技有限公司 | Pharmaceutical preparation for treating chronic pelvic inflammatory disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102370725B (en) | A kind of compound Chinese medicinal preparation treating chronic pelvic inflammatory disease and preparation method thereof | |
| CN105535694A (en) | Traditional Chinese medicine composition for treating hyperuricemia | |
| CN102908606A (en) | Traditional Chinese medicine for treating pregnancy vomiting | |
| CN102205105B (en) | Traditional Chinese medicine composition for treating chronic colitis | |
| CN104523865A (en) | Medicine for treating breast diseases | |
| CN103520461B (en) | Medicine for treating allergic rhinitis | |
| CN103393989B (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN103330826B (en) | Traditional Chinese medicine composition for treating deficiency of lung yin | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
| CN103417695A (en) | Traditional Chinese medicine for treating chronic pelvic inflammation | |
| CN104815092A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammation | |
| CN102335367B (en) | Medicine for treating pelvic inflammation | |
| CN103566242A (en) | Traditional Chinese medicinal paste for treating flat wart | |
| CN104436121B (en) | It is a kind of to treat irregular menstruation, small distention and fullness in the abdomen, the medicine to fail to be impregnated for a long time | |
| CN103611027B (en) | The pharmaceutical composition of a kind of clinical prevention, nursing and treatment trichomonal vaginitis | |
| CN102210846B (en) | Medicament for treating dysmenorrhea | |
| CN103610831B (en) | A kind of Chinese medicine for the treatment of neck and shoulder pain | |
| CN105770400A (en) | Traditional Chinese medicine composition for treating puerperal infection | |
| CN102935214B (en) | Traditional Chinese medicinal composition for treating uremia | |
| CN102475852A (en) | Traditional Chinese preparation for treating cervical spondylosis | |
| CN103933269A (en) | Traditional Chinese medicine for treating metrorrhagia disease | |
| CN103520591B (en) | Chinese medicine for chronic urticaria | |
| CN113491739B (en) | Pain-relieving and stasis-eliminating traditional Chinese medicine for treating endometriosis and preparation method thereof | |
| CN105250807A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150805 |